Human metapneumovirus vaccine

The present disclosure provides antigenic pre-fusion hMPV F polypeptides, nucleic acid sequences (e.g., RNA sequences, e.g., mRNA sequences) encoding pre-fusion hMPV F polypeptides, compositions comprising antigenic pre-fusion hMPV F polypeptides, compositions comprising nucleic acid sequences encod...

Full description

Saved in:
Bibliographic Details
Main Authors CHEN, YINGWEI, MUNDEL STEFAN, ANOSOVA NATALIA, STABLER ANDREAS, GROPP ROMAN, ZHANG LINONG, KIEWKULA STEPHEN, ALAMARES-SAPUE JOSE, STRUGNELL THOMAS, SAMALE SAMIR, DANZ HOLGER, DINAPOLI, JOSEPH, KISHORE MANISH
Format Patent
LanguageChinese
English
Published 12.07.2024
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present disclosure provides antigenic pre-fusion hMPV F polypeptides, nucleic acid sequences (e.g., RNA sequences, e.g., mRNA sequences) encoding pre-fusion hMPV F polypeptides, compositions comprising antigenic pre-fusion hMPV F polypeptides, compositions comprising nucleic acid sequences encoding pre-fusion hMPV F polypeptides, and hMPV vaccines. 本披露提供了抗原性融合前hMPV F多肽、编码融合前hMPV F多肽的核酸序列(例如,RNA序列,例如,mRNA序列)、包含抗原性融合前hMPV F多肽的组合物、包含编码融合前hMPV F多肽的核酸序列的组合物和hMPV疫苗。
Bibliography:Application Number: CN202280078895